The COVID-19 pandemic and global environmental change: Emerging research needs.

Biodiversity Chemicals Climate SARS-COV-2 Transformational change Urbanization

Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
01 2021
Historique:
received: 25 08 2020
revised: 22 10 2020
accepted: 06 11 2020
pubmed: 26 11 2020
medline: 6 1 2021
entrez: 25 11 2020
Statut: ppublish

Résumé

The outbreak of COVID-19 raised numerous questions on the interactions between the occurrence of new infections, the environment, climate and health. The European Union requested the H2020 HERA project which aims at setting priorities in research on environment, climate and health, to identify relevant research needs regarding Covid-19. The emergence and spread of SARS-CoV-2 appears to be related to urbanization, habitat destruction, live animal trade, intensive livestock farming and global travel. The contribution of climate and air pollution requires additional studies. Importantly, the severity of COVID-19 depends on the interactions between the viral infection, ageing and chronic diseases such as metabolic, respiratory and cardiovascular diseases and obesity which are themselves influenced by environmental stressors. The mechanisms of these interactions deserve additional scrutiny. Both the pandemic and the social response to the disease have elicited an array of behavioural and societal changes that may remain long after the pandemic and that may have long term health effects including on mental health. Recovery plans are currently being discussed or implemented and the environmental and health impacts of those plans are not clearly foreseen. Clearly, COVID-19 will have a long-lasting impact on the environmental health field and will open new research perspectives and policy needs.

Identifiants

pubmed: 33238229
pii: S0160-4120(20)32227-3
doi: 10.1016/j.envint.2020.106272
pmc: PMC7674147
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106272

Subventions

Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Références

Lancet Planet Health. 2020 May;4(5):e172
pubmed: 32389182
Lancet Infect Dis. 2016 Aug;16(8):971-9
pubmed: 27197551
PLoS Negl Trop Dis. 2019 Mar 28;13(3):e0007213
pubmed: 30921321
Environ Int. 2018 Dec;121(Pt 1):189-198
pubmed: 30216771
Sci Total Environ. 2015 Aug 15;524-525:319-30
pubmed: 25911543
Ann N Y Acad Sci. 2021 Feb;1486(1):15-38
pubmed: 33022781
Virus Evol. 2020 Dec 30;7(1):veaa098
pubmed: 33500788
Vet Sci. 2019 May 06;6(2):
pubmed: 31064099
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Ann N Y Acad Sci. 2019 Jan;1436(1):157-173
pubmed: 30120891
Lancet. 2020 Jan 11;395(10218):96-98
pubmed: 31929019
Lancet. 2018 Feb 3;391(10119):462-512
pubmed: 29056410
Glob Health Res Policy. 2020 Sep 1;5:39
pubmed: 32879902
Nature. 2020 Aug;584(7821):398-402
pubmed: 32759999
Am J Trop Med Hyg. 2020 Oct;103(4):1621-1629
pubmed: 32783794
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650
Nat Rev Microbiol. 2017 Aug;15(8):502-510
pubmed: 28555073
Lancet. 2020 Apr 25;395(10233):1327-1329
pubmed: 32394894
Int J Environ Res Public Health. 2020 Sep 30;17(19):
pubmed: 33008116
BMJ. 2020 Sep 2;370:m3169
pubmed: 32878746

Auteurs

Robert Barouki (R)

INSERM, Université de Paris, France. Electronic address: robert.barouki@parisdescartes.fr.

Manolis Kogevinas (M)

ISGlobal, Barcelona, Spain.

Karine Audouze (K)

INSERM, Université de Paris, France.

Ake Bergman (A)

Stockholm University, Sweden.

Sandra Boekhold (S)

RIVM, Netherlands.

Sebastien Denys (S)

Santé Publique France, France.

Celine Desseille (C)

INSERM, Université de Paris, France.

Elina Drakvik (E)

Stockholm University, Sweden.

Howard Frumkin (H)

University of Washington School of Public Health, USA.

Jeanne Garric (J)

INRAE, France.

Delphine Destoumieux-Garzon (D)

CNRS, Université de Montpellier, IFREMER, UPVD, France.

Anke Huss (A)

Utrecht University, Netherlands.

Genon Jensen (G)

Health and Environment Alliance (HEAL), Belgium.

Spyros Karakitsios (S)

Aristotle University of Thessaloniki, Greece.

Jana Klanova (J)

RECETOX, Masaryk University, Czech Republic.

Francine Laden (F)

Harvard T.H. Chan School of Public Health, USA.

Francelyne Marano (F)

Université de Paris, France.

George Morris (G)

ECEHH, University of Exeter, UK.

Julia Nowacki (J)

WHO European Centre for Environment and Health, Germany.

Riikka Paloniemi (R)

SYKE, Finland.

Neil Pearce (N)

CNRS, Université de Montpellier, IFREMER, UPVD, France.

Annette Peters (A)

HMGU, Germany.

Aino Rekola (A)

SYKE, Finland.

Denis Sarigiannis (D)

Aristotle University of Thessaloniki, Greece.

Katerina Šebková (K)

RECETOX, Masaryk University, Czech Republic.

Remy Slama (R)

INSERM, CNRS, Université de Grenoble-Alpes, IAB, France.

Cathryn Tonne (C)

ISGlobal, Barcelona, Spain.

Roel Vermeulen (R)

Utrecht University, Netherlands.

Paolo Vineis (P)

Imperial College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH